Heparin-induced thrombocytopenia: research and clinical updates.

Published

Journal Article (Review)

Heparin-induced thrombocytopenia (HIT) remains an important diagnosis to consider in hospitalized patients developing thrombocytopenia. HIT is an immune-mediated prothrombotic disorder caused by antibodies to platelet factor 4 (PF4) and heparin. Recent basic scientific studies have advanced our understanding of disease pathogenesis through studies of the PF4/heparin structure, immune mechanisms, and cellular basis of thrombosis. Clinical advances have also occurred in areas of HIT prevention, description of disease variants, and diagnostic strategies. Emerging anticoagulants with the potential to change HIT treatment are evolving, although with limited data. This review will provide a current perspective on HIT pathogenesis, disease features, diagnostic strategies, and role of emerging therapies for the management of HIT.

Full Text

Duke Authors

Cited Authors

  • Onwuemene, O; Arepally, GM

Published Date

  • December 2, 2016

Published In

Volume / Issue

  • 2016 / 1

Start / End Page

  • 262 - 268

PubMed ID

  • 27913490

Pubmed Central ID

  • 27913490

Electronic International Standard Serial Number (EISSN)

  • 1520-4383

Digital Object Identifier (DOI)

  • 10.1182/asheducation-2016.1.262

Language

  • eng

Conference Location

  • United States